Replies to post #8986 on BioSante Pharmaceuticals, Inc. (BPAX)

[Just the facts maam]

You are correct but I believe that the product will be marketed to 4 target groups

- Women with HHSD - not all post menopausal women suffer from HHSD
- Post menopausal women with testosterone deficiency
- Post menopausal women at risk to cardiovascular disease
- Improving cognitive function in menopausal and post menopausal women which is being studied in Australia

Clinical trial initiated to evaluate LibiGel on cognitive function in menopausal women